Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor

Area of Science:

• Cardiology
• Nuclear Medicine
• Cardiovascular Imaging

Background:

• Positron Emission Tomography (PET) is used to assess myocardial viability.
• Not all patients benefit from revascularization based on PET findings alone.
• Myocardial Perfusion Reserve (MPR) predicts survival in patients not undergoing revascularization.

Purpose of the Study:

• To investigate the relationship between MPR and survival in ischemic heart disease (IHD) patients after PET-guided intervention.
• To determine if MPR is a better predictor of outcomes than Left Ventricular Ejection Fraction (LVEF) and viability.

Main Methods:

• 119 consecutive chronic IHD patients underwent PET-guided revascularization (1995-2003).
• Procedures included percutaneous coronary interventions and coronary artery bypass grafts.
• Patients were followed for all-cause mortality and major adverse cardiovascular events.

Main Results:

• Lower MPR tertiles were associated with significantly higher cardiac mortality.
• MPR remained a significant predictor of cardiac death and major adverse cardiac events after adjusting for LVEF and viability.
• MPR demonstrated higher predictive value than LVEF and viability for cardiac death.

Conclusions:

• Patients with IHD undergoing PET-guided revascularization and low MPR are at increased risk for cardiac death.
• MPR is a more sensitive predictor of cardiac death in this population compared to LVEF and the extent of viability.
• MPR assessment can refine risk stratification in IHD patients undergoing revascularization.